Home
University of Bergen
Helga Bergljot Midtbø's picture
Photo:
Privat

Helga Bergljot Midtbø

Researcher
Department of Clinical Science
researchgate
orcid
  • E-mailhelga.midtbo@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

Senior researcher at The Center for Research on Cardiac Disease in Women at the University of Bergen (https://www.uib.no/en/femaleheart) and MD at the Department of Heart Disease, Haukeland University Hospital, Norway.

Reseach interests are cardiac imaging, cardiac disease in rheumatic diseases, sex & gender research, hypertension and obesity.

Publications midtbø h - Search Results - PubMed (nih.gov)

  1. Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø AB, Willems S, Gerdts E. Low myocardial energetic efficiency is associated with increased mortality in asymptomatic aortic valve stenosis. Open Heart 2021.
  2. Midtbø H, Gerdts E. Sex disparities in blood pressure development: time for action. Eur J Prev Cardiol 2021.
  3. Linde A, Gerdts E, Tveit KS, Kringeland E, Midbø H. Subclinical cardiac organ damage in patients with moderate to severe psoriasis. J Clin Med May 2021.
  4. Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd T, Gerdts E. Stage 1 hypertension is a stronger risk factor for acute coronary syndromes in women than in men: The Hordaland Health Study. In press Eur J Prev Cardiol 2021.
  5. Mancusi C, Midtbø H, De Luca N, Halland H, de Simone G, Gerdts E. Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study). J Clin Med 2021.
  6. Aune A, Kokorina M, Grytaas M, Midtbø H, Løvås K, Gerdts E. Preclinical cardiac disease in women and men with primary aldosteronism. Blood Pressure 2021.
  7. Midtbø H, Hauge SW, Haaverstad R, Dalen H. How reproducible is the diagnosis of borderline rheumatic heart disease? Int J Cardiol. Dec 2020.
  8. Einarsen E, Cramariuc D, Bahlmann E, Midtbø H, Chambers J, Gerdts E. Higher acceleration ejection time ratio predicts impaired outcome in non-severe aortic valve stenosis. Circulation: Cardiovascular Imaging 2021.
  9. Vo AK, Reikvam H, Midtbø H, Wirsching JL, Bruserud Ø, Wendelbo Ø. Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. Case Rep Anesthesiol Oct 2020.
  10. Pristaj N, Saeed S, Midtbø H, Halland H, Matre K, Gerdts E. Sex-specific Covariables of Myocardial Function in Subjects with Increased Body Mass Index. High Blood Press Cardiovasc Prev 2020.
  11. Kringeland E, Tell GS, Midtbø H, Haugsgjerd TR, Igland J, Gerdts E. Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. Blood Press 2020;13: 1-9.
  12. Os HA, Rollefstad S, Gerdts E, Kringeland E, Ikdahl E, Semb AG, Midtbø H. Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. Rheumatology Dec 2020.
  13. Herfindal B, Gerdts E, Kringeland EA, Saeed S, Midtbø H, Halland H. Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. J Hypertens. 2020: 38:1158-1164.
  14. Losi MA, Mancusi C, Midtbø H, Saeed S, de Simone G, Gerdts E. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. Int J Cardiol. 2019 Oct 3.
  15. Midtbø H, Semb AG, Matre K, Rollefstad S, Berg IJ, Jonsson R, Gerdts E. Left ventricular systolic myocardial function in ankylosing spondylitis. Arthritis Care Research 2019; 71: 1276-83.
  16. Lønnebakken MT, Eskerud I, Larsen TH, Midtbø H, Kokorina MV, Gerdts E. Impact of aortic stiffness on myocardial ischemia in non-obstructive coronary artery disease. Open Heart. 2019 May 4.
  17. Gerdts E, Saeed S, Midtbø H, Rossebø A, Chambers JB, Einarsens E, Bahlmann E, Devereux R. Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. Heart. 2019; 105:1629-33.
  18. Halland H, Matre K, Einarsen E, Midtbø H, Saeed S, Pristaj N, Lønnebakken MT, Gerdts E. Effect of fitness on left ventricular systolic myocardial function in overweight and obesity. Nutr Metab Cardiovasc Dis 2019; 29: 710-17.
  19. Einarsen E, Saeed S, Vramariuc D, Chambers JB, Midtbø H, Gerdts E. Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Stenosis Valve Replacement for Aortic Stenosis. Am J Cardiol 2019; 15: 942-47.
  20. Halland H, Lønnebakken MT, Pristaj N, Saeed S, Midtbø H, Einarsen E, Gerdts E. Sex differences in overweight and obesity. Nutr Metab Cardiovasc Dis 2018; 28: 1054-60.
  21. Midtbø H, Gerdts E, Berg IJ, Rollefstad S, Jonsson R, Semb AG. Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. The Journal of Rheumatology 2018 ; 45: 1249-55.
  22. Thomassen H, Giovanni C, Gerdts E, Einarsen E, Midtbø H, Cramariuc D. Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Heart 2017;103:1619- 24.
  23. Midtbø H, Semb AG, Matre K, Kvien TK, Gerdts E. Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. Ann Rheum Dis 2017; 76:371-376.
  24. Halland H, Lønnebakken MT, Saeed S, Midtbø H, Cramariuc D, Gerdts E. Does fitness improve cardiovascular risk profile in obese subjects? Nutr Metab Cardiovasc Dis 2017; 27:518-24.
  25. Kenny IE, Saeed S, Lønnebakken MT, Midtbø H, Halland H, Gerdts E. Prevalence and covariates of masked hypertension in obese subjects. Blood Pressure Monitoring. 2017; 22: 12-17.
  26. Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB. Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patient with left ventricular hypertrophy (the LIFE study). Blood Pressure 2016; 26: 150-55.
  27. Midtbø H, Gerdts E, Kvien TK, Olsen IC, Lønnebakken MT, Davidsen ES, et al. The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. Blood Press 2016; 25: 298-04.
  28. Valim V, Gerdts E, Jonsson R, Ferreira GA, Brokstad KA, Brun JG, Midtbø H, et al. Atherosclerosis in Sjogren's syndrome: evidence, possible mechanisms and knowledge gaps. Clin Exp Rheumatol 2016;34:133-42.
  29. Midtbø H, Gerdts E, Kvien TK, Olsen IC, Hirth A, Davidsen ES, et al. Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology (Oxford) 2015; 54:511-9.
  30. Midtbø H, Hirth A, Norgård G, Greve G. Do patients with ventricular septal defect need endocarditits prophylaxis?. Tidsskr Nor Laegeforen 2005; 25:3256-8.

Twitter